Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 16 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulationDegenhardt, L.; Larance, B.; Bell, J.; Winstock, A.; Lintzeris, N.; Ali, R.; Scheuer, N.; Mattick, R.
2021The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort studyBharat, C.; Larney, S.; Barbieri, S.; Dobbins, T.; Jones, N.R.; Hickman, M.; Gisev, N.; Ali, R.; Degenhardt, L.
2020Data resource profile: the Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, AustraliaLarney, S.; Jones, N.; Fiellin, D.A.; Nielsen, S.; Hickman, M.; Dobbins, T.; Murphy, T.; Ali, R.; Degenhardt, L.
2018Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) StudyLarney, S.; Hickman, M.; Fiellin, D.A.; Dobbins, T.; Nielsen, S.; Jones, N.R.; Mattick, R.P.; Ali, R.; Degenhardt, L.
2021Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomesJones, N.R.; Nielsen, S.; Farrell, M.; Ali, R.; Gill, A.; Larney, S.; Degenhardt, L.
2016Diversion and injection of buprenorphine-naloxone film two years post-introduction in AustraliaLarance, B.; Mattick, R.; Ali, R.; Lintzeris, N.; Jenkinson, R.; White, N.; Kihas, I.; Cassidy, R.; Degenhardt, L.; Wilkinson, C.; Livingston, M.
2015Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocolDegenhardt, L.; Larance, B.; Bruno, R.; Lintzeris, N.; Ali, R.; Farrell, M.
2015A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodonePeacock, A.; Degenhardt, L.; Larance, B.; Cama, E.; Lintzeris, N.; Ali, R.; Bruno, R.
2015Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioidsPeacock, A.; Bruno, R.; Cama, E.; Kihas, I.; Larance, B.; Lintzeris, N.; Hordern, A.; White, N.; Ali, R.; Degenhardt, L.
2022Examining the cost and impact of dosing fees among clients in opioid agonist treatment: results from a cross-sectional survey of Australian treatment clientsZahra, E.; Chen, R.; Nielsen, S.; Tran, A.D.; Santo, T.; Degenhardt, L.; Farrell, M.; Byrne, J.; Ali, R.; Larance, B.